Deutsche Bank Reiterates Buy on Tenet Healthcare (THC), Raises PT

March 8, 2013 12:46 PM EST
Get Alerts THC Hot Sheet
Price: $18.10 +0.28%

Rating Summary:
    12 Buy, 15 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade THC Now!
Join SI Premium – FREE
Deutsche Bank today reiterated a Buy rating on Tenet Healthcare (NYSE: THC) and raised its price target to $46.00 (from $43.00). Analysts said Tenet's outlook remains good an visibility is sold.

"We continue to believe THC has solid visibility into its 2013 EBITDA growth," said analyst Darren Lehrich. "THC's implied outlook is for ~4% to ~4.5% organic growth in 2013, which seems very do-able given the fact that it is still gaining market share in the higher margin outpatient setting, has had very solid same-store volume growth relative to the peer group in recent quarters (SS adjusted admissions in 2012 were +2.2% vs. peers +0.8%), and has good pricing visibility in its MCO book."

For an analyst ratings summary and ratings history on Tenet Healthcare (NYSE: THC) click here. For more ratings news on Tenet Healthcare click here.

Shares of Tenet Healthcare closed at $41.76 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Deutsche Bank

Add Your Comment